Biomarkers · Inflammation

Interleukin-10 (IL-10)

No risk curve catalogued yet.

IL-10 by age and sex

Each bar runs from the 5th to the 95th percentile, the darker part from the 25th to the 75th, and the tick is the median. Not a reference range or a target.

The percentiles as a table

Each row is one sex and age band: the values below which 5%, 25%, 50%, 75% and 95% of people fall (pg/mL), from the survey named in the row. Not a reference range or a target.
Sex	Age	5th	25th	Median	75th	95th	n	Cycle / source
All	40-59	0.11	0.17	0.23	0.34	0.99	353	MIDUS 3 Biomarker Proj…
All	60+	0.12	0.18	0.25	0.37	0.76	394	MIDUS 3 Biomarker Proj…
All	all	0.11	0.18	0.24	0.36	0.86	747	MIDUS 3 Biomarker Proj…
Men	40-59	0.11	0.17	0.23	0.35	1.04	135	MIDUS 3 Biomarker Proj…
Men	60+	0.12	0.18	0.25	0.36	0.82	195	MIDUS 3 Biomarker Proj…
Men	all	0.12	0.18	0.24	0.36	0.89	330	MIDUS 3 Biomarker Proj…
Women	40-59	0.11	0.17	0.24	0.34	0.88	218	MIDUS 3 Biomarker Proj…
Women	60+	0.11	0.18	0.25	0.37	0.74	199	MIDUS 3 Biomarker Proj…
Women	all	0.11	0.18	0.25	0.36	0.82	417	MIDUS 3 Biomarker Proj…

What studies found when this marker was changed

They describe what happened in those study groups, not a recommendation. See all catalogued interventions.

Measured changes in IL-10, study by study

1 effect with a numeric size, each from one study arm: the dot is the reported change, the line its 95% interval where one was given. Study results in the groups studied, not predictions for a person.

Each row is one study: what was changed, the effect it reported on this marker, and the source.
Type	Intervention	Reported effect	Evidence	Source
diet	Diet with palmitic acid-rich interesterified fat vs stearic acid-rich interesterified fat (10% of energy) for 6 weeks in healthy adults	IL-10 fell 0.14 pg/mL (95% CI -0.23 to -0.06) on palmitic vs stearic acid-rich fat at 6 weeks; crossover, forty-seven completers	RCT	Hall WL, et al. Am J Clin Nutr. 2025;122(5):1361-1373.

Sources

See the catalogue entry in the research dashboard.